GHR and hepatocellular carcinoma: In addition, our results showed that the protein level of p-ERK1/2 was also inhibited in HCC cells with si GHR and sorafenib combination in relative to control cells, suggesting ERK1/2 inactivation might be another mechanism of GHR silence sensitizing HCC cells to sorafenib.